Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Melatonin receptor ligands exert potent effects on circadian rhythms

July 18, 2001

Transdermal dopamine agonist reduces levodopa use in PD

July 18, 2001

Sepracor preparing for NDA submission of insomnia drug candidate

July 17, 2001

Treatment of mild cognitive impairment with glucocorticoid receptor antagonists

July 17, 2001

Pharmacia receives nonapprovable letter from FDA for analgesic product

July 17, 2001

Nerve injury-induced gene discovered by Washington University scientists

July 17, 2001

Preclinical pipeline at Faes includes new antidepressant and antipsychotic agents

July 17, 2001

Venlafaxine metabolite ethers with same pharmacological profile as venlafaxine

July 13, 2001

Urotensin II analogues and pharmaceutical compositions for stroke and other disorders

July 13, 2001

Sea cucumber-based therapy useful for age-associated dementia

July 13, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...